Natural Supplements Proven to Lower Cholesterol & Triglycerides
A Research Report
by
Dr. James Meschino, D.C., M.S., N.D.
Clinical Director, RenaiSanté Institute of Integrative Medicine
I
NTRODUCTION
High cholesterol and/or triglyceride problems are
very common in modern society and are known to
increase risk for heart attack, stroke and other
cardiovascular diseases. Individuals should strive to
achieve a fasting blood cholesterol level below 3.9
mmol/L (150 mg/d) and a fasting triglyceride level below
1.13 mmol/L (100 mg/dL) to maximize their protection
against heart attack and stroke. Eating less high fat
animal products and consuming foods high in cholesterol
lowering fiber is most beneficial in this regard (beans,
peas, oats, fruits vegetables, ground flaxseed, psyllium).
In addition, there are two natural agents that have
proven cholesterol and triglyceride lowering effects that
can be used to complement a diet and lifestyle plan
aimed at lowering these two cardiovascular risk factors.
These two natural agents include Gugulipid and
Artichoke Leaf. When taken at the right dosage and
standardized grade these two supplements work
synergistically to lower cholesterol and/or triglyceride to
a significant degree, in persons with elevated blood
levels.
G
UGULIPID
Gugulipid is a natural health product that has been
shown to reduce elevated blood cholesterol and
triglyceride levels, in the prevention of cardiovascular
disease. It has been used for many years for this
purpose in India, where it is has received prescription
drug status, due to its high level of efficacy, as
determined in human clinical trials. Remarkably,
Gugulipid is very safe drug relative to most cholesterollowering
drugs used in modern medicine (especially
when compared to the commonly used statin drugs,
which inhibit the HMG-CoA Reductase enzyme in the
liver, and can lead to liver damage). Gugulipid shows a
similar therapeutic effect to many cholesterol-lowering
drugs without any apparent risk of liver damage.
Gum Guggul or Gugulipid is derived from the mukul
myrrh tree, which is native to India. Upon injury, the tree
exudes a yellowish gum resin known as gum Guggul,
Gugulipid or Guggulu. The extract isolates ketonic
steroid compounds known as guggulsterones have been
shown to be the active constituent that account for its
cholesterol and triglyceride lowering effects.
Gugulipid was granted approval in India for
marketing as a lipid-lowering drug in June 1986. Studies
show that it lowers total cholesterol, LDL cholesterol,
while elevating HDLcholesterol (the good cholesterol)
levels. (Agarwal RC, 1986 and Nityanand S,1989). It
appears that guggulsterones increase the uptake of LDL
cholesterol from the blood by the liver. Studies in
humans demonstrate that guggulsterone can produce a
cholesterol reduction of 14-27%, in 4-12 weeks, and a
22-30% drop in blood triglyceride levels, in patients with
high cholesterol and/or high triglycerides. A striking
feature is its lack of toxicity. Unlike other cholesterol
lowering drugs, the administration of Gugulipid has not
revealed any significant side effects, liver damage or
toxicity, in human or animal studies to date.
A
RTICHOKE LEAF EXTRACT
Artichoke leaf extract is known to increase bile acid
secretion by the liver, which in turn, increases LDLcholesterol
receptor production in liver cell, clearing
more LDL cholesterol from the blood stream. This results
in a lowering of blood cholesterol. Cholesterol is the
building block of bile acids. Hence, artichoke enhances
the excretion of excess cholesterol (in the form of bile)
from the body via the fecal route. It is though that
cynarin, a compound in artichoke called luteolin may
play a role in reducing cholesterol. There is also
evidence that artichoke extract inhibits cholesterol
synthesis in the liver, to some degree, which also helps
to lower blood cholesterol levels.
In a double-blind, placebo-controlled study of 143
people with high cholesterol, artichoke leaf extract
reduced total cholesterol by 18.5% as compared to 8.6%
in the placebo group; LDL cholesterol dropped by 23%
vs. 6%; and LDL-to-HDL ratios declined by 20% vs. 7%.
(Englisch W et al. 2000). Like Gugulipid Artichoke leaf
extract is not associated with any significant side effects
or toxicity.
D
OSAGE AND STANDARDIZED GRADES
To be effective, Gugulipid must be standardized to
yield 50-75 mg of gugglesterones per day (example
1,000 mg dose, standardized to 2.5% guggulsterone
content, taken two to three times per day). Artichoke leaf
extract requires a minimum of 400 mg (standardized to
13-18% caffeoylquinic acids), taken two to three times
per day. Look for products that contain standardized
grades of both Gugulipid and Artichoke Leaf, and
provide the ideal dosage for cholesterol and triglyceride
lowering. The synergistic effect of Gugulipid and
Artichoke Leaf Extract provide a natural and safe means
to help lower cholesterol. This combination can even be
taken safely in conjunction with other cholesterol and
triglyceride-lowering medications, if necessary.
G
UGULIPID REFERENCES
Murray MT, The Healing Power of Herbs (2nd edition),
Prima Publishing, 1995.
Satyavati GV, A Primising Hypolipidaemic Agent from
Gum Guggul (Commiphora Wightii), Econ Med Plant Res
5, 1991, 47-82.
Nityand S and Kapoor NK, Hypocholesterolemic Effect of
Commiphora Mukul Resin, Indian J Exp Biol 9, 1971, 376-
377.
Kuppurajan K, et.al., Effect of Gugglu on Serum Lipids in
Obese Hypercholesterolemic and Hyperlipidemic Cases, J
Assoc Physicians India 26, 1978, 367-371.
Malhotra SC, Ahuja MMS, and Sundaram KR, Long Term
Clinical Studies on the Hypolipidaemic Effect of
Commiphora Mukul (Guggulu) and Clofibrate, Indian J
Med Res 65, 1977, 390-395.
Verna SK and Bordia A, Effect of Commiphora Mukul
(Gum Guggulu) in Patients of Hyperlipidemia with Special
Reference to HDL cholesterol, Indian J Med Res 87,
1988, 356-360.
Agarwal RC, et.al., Clinical Trial of Gugulipid a New
Hypolipidemicagent of Plant Origin in Primary
Hyperlipidemia, Indian J Med Res 84, 1986, 626-634.
Nityanand S, Srivastava JS, and Asthana OP. Clinical
Trials with Gugulipid, a New Hypolipidaemic Agent, J
Assoc Physicians India 37, 1989, 321-328.
Singh V, et.al., Stimulation of Low Density Lipoprotein
Receptor Activity in Liver Membrane of Guggulsterone
Treated Rats, Pharmocol Res 22, 1990, 37-44.
Sharma JN and Sharma JN, Commparison of the Antiinflammatory
Activity of Commiphora Mukul (an
indigenous drug) with those Pfhenylbutazone and
Ibuprofen in Experimental Arthritis Induced by
Mycobacterial Adjuvant, Arzneimittel-Forsch 27, 1977,
1455-1457.
Dietary Supplement Information Bureau.
www.content.intramedicine.com: Guggul.
Natural Health Products Encyclopedia.
www.consumerslab.com: Guggul.
Healthnotes, Inc.200.www.healthnotes.com: Guggul
Satyavati GV. Gum guggul (Commiphora mukul) The
success of an ancient insight leading to a modern
discovery. Indian J Med 1988;87:327-35
Singh RB, Niaz MA, Ghosh S. Hypolipidemic and
antioxidant effects of Commiphora mukul as an adjunct to
dietary therapy in patients with hypercholesterolemia.
Cardiovasc Drugs Ther 1994;8:659-64
Singh K, Chander R, Kapoor NK. Guggulsterone, a potent
hypolipidaemic, prevents oxidation of low density
lipoprotein. Phytother Res 1997;11:291-4
Mester L, Mester M, Nityanand S. Inhibition of platelet
aggregration by guggulu steroids. Planta Med
1979;37:367-9
Satyavati GV et al. Experimental studies on the
hypocholesterolemic effect of commiphora mukul. Indian J
Med Res 1969;57(10):1950-62
Nityanand S et al. Clinical trials with gugulipid. A new
hypolipidaemic agent. J Assoc Physicians India
1989;37(5):323-8
Satyavati GV et al. Guggulipid: a promising Hypolipidemic
agent from gum guggul (Commiphora Wightii). Econ Med
Plant Res 1991;5:48-82
A
RTICHOKE LEAF REFERENCES
Englisch W, Beckers C, Unkauf M, et al. Efficacy of
artichoke dry extract in patients with hyperlipoproteinemia.
Arzneimittelforschung. 2000;50:260265.
Kraft K. Artichoke leaf extractrecent findings reflecting
effects on lipid metabolism, liver and gastrointestinal
tracts. Phytomedicine. 1997;4:369378.
Englisch W, Beckers C, Unkauf M, et al. Efficacy of
artichoke dry extract in patients with hyperlipoproteinemia.
Arzneimittelforschung. 2000;50:260265.
Petrowicz O, Gebhardt R, Donner M, et al. Effects of
artichoke leaf extract (ALE) on lipoprotein metabolism in
vitro and in vivo [abstract]. Atherosclerosis. 1997;129:147.
Kraft K. Artichoke leaf extractrecent findings reflecting
effects on lipid metabolism, liver and gastrointestinal